Revenues in USD of PFIZER INC from 2020 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Pfizer Inc quarterly/annual Revenues history and growth rate from 2020 to Q3 2025.
- Pfizer Inc Revenues for the quarter ending September 28, 2025 was $16.7B, a 5.92% decline year-over-year.
- Pfizer Inc Revenues for the twelve months ending September 28, 2025 was $62.8B, a 3.89% increase year-over-year.
- Pfizer Inc annual Revenues for 2024 was $63.6B, a 6.84% increase from 2023.
- Pfizer Inc annual Revenues for 2023 was $59.6B, a 41.1% decline from 2022.
- Pfizer Inc annual Revenues for 2022 was $101B, a 24.5% increase from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)